Stockscreener 앱 받기
17.89
2.05%
0.36
시장 영업 전:
17.78
-0.11
-0.61%
전일 마감가:
$17.53
열려 있는:
$17.65
하루 거래량:
7.16M
Relative Volume:
0.76
시가총액:
$9.24B
수익:
$11.32B
순이익/손실:
$-981.00M
주가수익비율:
-9.1593
EPS:
-1.9532
순현금흐름:
$714.00M
1주 성능:
+6.81%
1개월 성능:
+4.31%
6개월 성능:
-4.33%
1년 성능:
-43.88%
1일 변동 폭
$17.50
$18.05
1주일 범위
$16.86
$18.09
52주 변동 폭
$15.73
$32.04
박스터 인터내셔널 Stock (BAX) Company Profile
명칭
Baxter International Inc
전화
(224) 948-2000
주소
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
17.89 | 9.05B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
박스터 인터내셔널 Stock (BAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-31 | 다운그레이드 | Argus | Buy → Hold |
| 2025-08-04 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-08-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-02-26 | 재개 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | Argus | Hold → Buy |
| 2025-02-20 | 재개 | Barclays | Overweight |
| 2024-07-15 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-12-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-15 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-12-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-06-24 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-18 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-18 | 재확인 | Raymond James | Outperform |
| 2022-02-18 | 재확인 | Stifel | Buy |
| 2022-02-18 | 재확인 | UBS | Neutral |
| 2022-02-18 | 재확인 | Wells Fargo | Overweight |
| 2022-02-11 | 개시 | Goldman | Neutral |
| 2022-01-07 | 재개 | Citigroup | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-09-03 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-09-04 | 다운그레이드 | Argus | Buy → Hold |
| 2020-06-24 | 개시 | Oppenheimer | Outperform |
| 2020-03-19 | 업그레이드 | Stifel | Hold → Buy |
| 2020-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-01-02 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | 업그레이드 | Argus | Hold → Buy |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-05-17 | 재개 | Piper Jaffray | Overweight |
| 2018-02-06 | 재확인 | Citigroup | Neutral |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2018-01-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
박스터 인터내셔널 주식(BAX)의 최신 뉴스
Baxter International Inc. stock (US0673431090): Recent 2% price gain on NYSE - AD HOC NEWS
Baxter International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Baxter International Inc stock (US0718131099): Shares drop 2.56% to $17.53 - AD HOC NEWS
Baxter International earnings preview: What to expect - MSN
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Rare Hemophilia Factors Market Is Going to Boom |• Baxter International • Novo Nordisk • Pfizer - openPR.com
Baxter International Inc. stock (US0673431090): Q1 2026 earnings beat consensus - AD HOC NEWS
Precision Trading with Baxter International Inc. (BAX) Risk Zones - Stock Traders Daily
Baxter International shareholders approve board slate, pay and incentive plan at annual meeting - MSN
Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting - TradingView
Baxter International Inc. stock (US0673431090): Governance shake?up and earnings pressure in focus - AD HOC NEWS
Baxter Updates Executive Severance Plan and Governance Framework - TipRanks
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International updates executive severance plan and amends bylaws after annual meeting - Investing.com
Baxter (NYSE: BAX) expands severance protections and adds 20M incentive shares - Stock Titan
Infusion Therapy Market Is Going to Boom | Baxter International, B. Braun Melsungen AG, Fresenius Kabi AG - openPR.com
BAX Stock Price, Quote & Chart | BAXTER INTERNATIONAL INC (NYSE:BAX) - ChartMill
Baxter International Still Has A Path To Upside - Seeking Alpha
Director at Baxter (NYSE: BAX) receives 12,836 fully vested share award, now holds 37,076 - Stock Titan
Baxter (BAX) director Amy McBride receives 12,836-share fully vested stock grant - Stock Titan
Director at Baxter (NYSE: BAX) awarded 12,836 shares, holds 34,994 - Stock Titan
Baxter International (BAX) director awarded 12,836 fully vested shares - Stock Titan
Baxter (BAX) board chair David Brent Shafer receives 12,836-share stock grant - Stock Titan
Director Michael McDonnell of Baxter (NYSE: BAX) receives 12,836-share fully vested grant - Stock Titan
Director Jeffrey A. Craig receives 12,836 Baxter (BAX) shares in grant - Stock Titan
Baxter (NYSE: BAX) director awarded 12,836 fully vested shares in Form 4 - Stock Titan
MSN Money - MSN
Becton Dickinson at 13x Earnings: MedTech’s Most Mispriced Compounder - Investing.com
Baxter International Inc. stock rises Wednesday, still underperforms market - MarketWatch
FMR LLC reports 9.0% stake in Baxter International (BAX) — 46.3M shares - Stock Titan
Assessing Baxter International’s Valuation After Earnings Beat And Guidance Reaffirmation - simplywall.st
Pheochromocytoma Market to Reach USD 3.86 Billion by 2033 at 8.5% - openPR.com
Franklin Mutual U.S. Mid Cap Value Fund's Baxter International Inc(BAX) Holding History - GuruFocus
The Adirondack Small Cap Fund's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter International Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
Barclays Maintains Baxter International Inc(BAX.US) With Buy Rating, Maintains Target Price $27 - Moomoo
Baxter International Inc. (BAX) Stock Analysis: Exploring a 28.5% Potential Upside for Healthcare Investors - DirectorsTalk Interviews
Research Alert: CFRA Keeps Hold Rating On Shares Of Baxter International Inc. - 富途牛牛
Baxter International 1Q Loss $15M >BAX - Moomoo
Assessing Baxter International (BAX) Valuation After Earnings Beat And Reaffirmed Outlook - Yahoo Finance
Baxter International Inc. (NYSE:BAX) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
Baxter International (BAX) Is Down 5.2% After Q1 Loss But Turnaround Guidance ReaffirmedWhat's Changed - Yahoo Finance
Baxter Profit Plunges 35% As Tariffs, Costs Bite - Sahm
Baxter International (NYSE:BAX) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says - MarketBeat
Baxter International (NYSE:BAX) Given New $19.00 Price Target at Stifel Nicolaus - MarketBeat
Baxter International (NYSE:BAX) Stock Price Expected to Rise, Barclays Analyst Says - MarketBeat
Baxter International Inc. Q1 2026 Financial Results: Revenue, Earnings, and Key Financial Statements - Minichart
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
symbol__ Stock Quote Price and Forecast - CNN
Baxter International Inc. (NYSE:BAX) to Issue Quarterly Dividend of $0.01 - MarketBeat
Barclays Adjusts Baxter International Price Target to $27 From $25 - marketscreener.com
박스터 인터내셔널 (BAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.64%
3.17%
자본화:
|
볼륨(24시간):